Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19,704Revenue $M730Net Margin (%)11.8Z-Score53.0
Enterprise Value $M18,847EPS $1.1Operating Margin %16.8F-Score5
P/E(ttm))238Cash Flow Per Share $0.2Pre-tax Margin (%)16.8Higher ROA y-yN
Price/Book23.510-y EBITDA Growth Rate %0Quick Ratio5.1Cash flow > EarningsY
Price/Sales27.55-y EBITDA Growth Rate %0Current Ratio5.2Lower Leverage y-yY
Price/Cash Flow306y-y EBITDA Growth Rate %31.1ROA % (ttm)9.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)12.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M76.0ROI % (ttm)2.8Gross Margin Increase y-yN

Gurus Latest Trades with PCYC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
PCYCJoel Greenblatt 2014-12-31 Buy $103.79 - $141.55
$ 256.5950%New holding2,619
PCYCJoel Greenblatt 2014-09-30 Sold Out -0.09%$91.5 - $127.81
$ 256.5955%Sold Out0
PCYCKen Fisher 2014-09-30 Reduce$91.5 - $127.81
$ 256.5955%Reduce -36.57%3,244
PCYCJoel Greenblatt 2014-06-30 Add0.08%$85.85 - $107.42
$ 256.5963%Add 724.62%79,089
PCYCMariko Gordon 2014-06-30 Sold Out -0.04%$85.85 - $107.42
$ 256.5963%Sold Out0
PCYCKen Fisher 2014-06-30 Buy $85.85 - $107.42
$ 256.5963%New holding5,114
PCYCMariko Gordon 2014-03-31 Add0.02%$100.49 - $151.61
$ 256.5949%Add 112.41%9,295
PCYCJoel Greenblatt 2014-03-31 Buy 0.01%$100.49 - $151.61
$ 256.5949%New holding9,591
PCYCMariko Gordon 2013-12-31 Add0.01%$99.28 - $139.59
$ 256.5953%Add 130.07%4,376
PCYCMariko Gordon 2013-09-30 Buy 0.01%$84.5 - $132.49
$ 256.5957%New holding1,902
PCYCJoel Greenblatt 2013-03-31 Sold Out -0.14%$57.78 - $94.2
$ 256.5970%Sold Out0
PCYCJoel Greenblatt 2012-12-31 Buy 0.14%$47.87 - $69.78
$ 256.5977%New holding41,832
PCYCGeorge Soros 2012-06-30 Sold Out -0.04%$25.72 - $53.44
$ 256.5987%Sold Out0
PCYCGeorge Soros 2012-03-31 Buy 0.04%$14.99 - $28.68
$ 256.5992%New holding100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCYC is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

PCYC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Soni Manmeet SinghCFO 2015-03-13Sell27,514$254.240.92view
Tan HeowChief Quality&Tech Operations 2015-03-12Sell1,000$254.510.82view
Zanganeh MakyCOO 2015-03-11Sell30,000$254.110.98view
Zanganeh MakyCOO 2015-03-11Sell30,000$254.110.98view
Soni Manmeet SinghCFO 2014-11-13Sell1,000$141.4481.41view
Fardis MariaChief of Oncology Ops & Allian 2014-11-13Sell3,000$141.381.59view
Zanganeh MakyCOO 2014-11-12Sell30,482$134.6990.5view
Love Richard BGeneral Counsel 2014-11-10Sell1,500$133.8791.67view
Fardis MariaChief of Oncology Ops & Allian 2014-11-07Sell5,000$134.590.77view
Zanganeh MakyCOO 2014-09-04Sell12,000$121.75110.75view

Press Releases about PCYC :

    Quarterly/Annual Reports about PCYC:

    News about PCYC:

    Articles On GuruFocus.com
    AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board Apr 24 2015 
    Weekly Insider Sells Highlight: PCYC, DIS, AZO, SCI Mar 17 2015 
    AbbVie Strikes The Biggest Deal For Treatment Of Cancer Mar 10 2015 
    AbbVie To Acquire Biopharmaceutical Firm Pharmacyclics Mar 06 2015 
    own Mar 02 2015 
    Weekly 52-Week Highs Highlight: DG, AGN, ADSK, AVGO, PCYC Feb 22 2015 
    Weekly Insider Sells Highlight: BX, PCYC, MAS, ITMN Mar 03 2014 
    comment on PCYC Mar 06 2013 
    Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 
    Pharmacyclics Inc. Reports Operating Results (10-Q) Feb 08 2011 

    More From Other Websites
    Biz Break: The 2015 SV150: Apple in command, Wall Street has demands Apr 24 2015
    Comcast Is Reportedly Throwing In the Towel on Time Warner Cable Apr 24 2015
    AbbVie (ABBV) Earnings Report: Q1 2015 Conference Call Transcript Apr 24 2015
    AbbVie Profit Rises on Broad Sales Growth Apr 23 2015
    AbbVie Beats Earnings on Humira and HCV Sales, Ups View - Analyst Blog Apr 23 2015
    AbbVie: Wait, I Thought It Was Good News? Apr 23 2015
    Abbvie's CEO Gonzalez: We're Now In Pharma's 'Top Tier' Apr 23 2015
    Pharmacyclics Announces Positive Results on Imbruvica - Analyst Blog Apr 21 2015
    Is AbbVie (ABBV) Set to Top 1Q Earnings on Humira & HCV? - Analyst Blog Apr 21 2015
    It has been a historic year for biotech mergers and it might not be over yet Apr 21 2015
    Forget Gilead (GILD), Buy These Impressive Biotech Stocks Instead - Analyst Blog Apr 21 2015
    Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent Apr 20 2015
    Ibrutinib (IMBRUVICA®) Improves Outcomes for Pancreatic Ductal Adenocarcinoma in Mouse Models Apr 20 2015
    IMBRUVICA® (ibrutinib) Longer-Term Follow-Up Data Demonstrate Durable Responses, Including Complete... Apr 20 2015
    AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. Apr 17 2015
    Basics of the Informatica Merger Apr 16 2015
    The Informatica Merger Spread Currently Yields About 4% Apr 16 2015
    The Zacks Analyst Blog Highlights: Pfizer, Pharmacyclics, Geron, Anthera Pharmaceuticals and Cytori... Apr 16 2015
    3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog Apr 15 2015
    [$$] J&J’s Profit Falls on Strong Dollar, Weak Medical-Device Sales Apr 14 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)